Celgene, Novartis Settle With Teva In Focalin IP Suits
Celgene Corp. and Novartis Pharmaceuticals Corp. have settled a series of lawsuits against Teva Pharmaceuticals USA Inc. over its plan to market a generic version of attention deficit hyperactivity disorder treatment...To view the full article, register now.
Already a subscriber? Click here to view full article